TG Therapeutics Inc (TGTX) (Q3 2026) Earnings Call Highlights: Revenue Jumps 61% as Guidance ...
TG Therapeutics’ CEO Sees Global Revenue Exceeding $1B In 2026 – BRIUMVI Drives Q3 Topline Beat
TG Therapeutics Reports Third Quarter 2026 Financial Results and Raises Full-Year Revenue Guidance
Loading...